Skip To Main Content
Implementation” Lab on Muck Rack

Implementation” Lab

As seen in: The Lancet
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Implementation”

Contact Implementation”, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Psychotic symptoms during pharmacological treatment of ADHD: clinical considerations and research needs

|
By Samuele Cortese, Developmental “Evidence, Implementation” Lab
| The Lancet Verified
Get full text access Log in, subscribe or purchase for full access. References 1. Chan, AYL ∙ Ma, TT ∙ Lau, WCY ∙ et al. Attention-deficit/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: a longitudinal study EClinicalMedicine. 2023; 58, 101780 2. Cortese, S ∙ Holtmann, M ∙ Banaschewski, T ∙ et al.
Open in Who Shared Issue with article?

Pharmacological interventions for ADHD: a systematic review and dose–effect network meta-analysis

|
By Mikail Nourredine, Implementation” Lab, Hospices Civils de Lyon
| The Lancet Verified
Introduction ADHD is a common neurodevelopmental condition, characterised by a persistent and impairing pattern of inattention or hyperactivity–impulsivity that is inconsistent with the developmental stage.1,2 It affects approximately 5% of children worldwide,3 and in 40–70% of cases, impairing symptoms persist beyond adolescence, with an estimated prevalence in adults of about 3%.4 ADHD is associated, on average, with an elevated risk of adverse outcomes, although trajectories vary across...
Open in Who Shared Issue with article?
See all 2 articles